{"text_format":"2","workbook":"xlsx","n_sheets":1,"sheets":["Sheet1"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":0,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Sheet1","index":0,"n_rows":35,"n_cols":4,"rows_kept":35,"cut":false,"hidden":false,"merged":[]}
["drug_name","disease_id","gene_id","jacc_idx"]
["AFLIBERCEPT",5,5,5]
["AXITINIB",10,10,10]
["BEVACIZUMAB",5,5,5]
["BUTAMBEN",5,5,5]
["BUTAMBEN PICRATE",5,5,5]
["CABOZANTINIB",5,5,5]
["CABOZANTINIB S-MALATE",5,5,5]
["CANNABIDIOL",5,5,5]
["CARVEDILOL",5,5,5]
["DEXIBUPROFEN",5,5,5]
["DOCETAXEL",5,5,5]
["ERDAFITINIB",5,5,5]
["ERIBULIN",5,5,5]
["FOSTAMATINIB",10,10,10]
["GLICLAZIDE",5,5,5]
["IBUPROFEN",5,5,5]
["ISOSORBIDE",5,5,5]
["LENVATINIB",10,10,10]
["MIDOSTAURIN",5,5,5]
["MINOCYCLINE",5,5,5]
["NINTEDANIB",10,10,10]
["PACLITAXEL",5,5,5]
["PAZOPANIB",10,10,10]
["PEGAPTANIB SODIUM",5,5,5]
["PONATINIB",5,5,5]
["RAMUCIRUMAB",5,5,5]
["RANIBIZUMAB",5,5,5]
["RASAGILINE",5,5,5]
["REGORAFENIB",10,10,10]
["ROMOSOZUMAB",5,5,5]
["SORAFENIB",10,10,10]
["SUNITINIB",10,10,10]
["VANDETANIB",5,5,5]
["VENETOCLAX",5,5,5]